Company news
PharmaEssentia Corp. news in 2024
PharmaEssentia Corp.'s news releases, calls and decks from 2024, newest first.
PharmaEssentia to Present at the Annual J.P. Morgan Healthcare Conference on January 16, 2025
December 19, 2024
PharmaEssentia Appoints Joseph R. Horvat as Global Chief Commercial Officer
December 5, 2024
PharmaEssentia Announces Nine Data Presentations at ASH Annual Meeting
November 25, 2024
PharmaEssentia Announces Licensing Agreement with FORUS Therapeutics to Commercialize BESREMi® (ropeginterferon alfa-2b-njft) in Canada
September 4, 2024
PharmaEssentia Appoints Beth A. Krewson as Head of Legal
July 23, 2024
PharmaEssentia - ANALYSES FIND PATIENTS WITH POLYCYTHEMIA VERA TREATED WITH BESREMI HAD INCREASED PROBABILITY OF ACHIEVING COMPLETE HEMATOLOGIC RESPONSE
April 2, 2024